# Texas DIR/ESBD #HHS0018069

Texas HHS seeks rapid hepatitis C antibody test kits and quality-control kits

**Posted:** November 20, 2026
**Respond By:** December 15, 2026
**Identifier:** HHS0018069
**NAICS:** 325413, 423450

Texas health agencies are seeking rapid hepatitis C screening kits and related quality controls for the DSHS pharmacy inventory system.
- **Government buyer**
  - Texas Health and Human Services Commission (HHSC), Procurement and Contracting Services, for the Texas Department of State Health Services (DSHS); HHSC and DSHS may use a resulting contract.
- **Products requested**
  - Estimated annually: 4,000 FDA-approved, CLIA-waived rapid point-of-care hepatitis C virus (HCV) antibody test kits and 15 associated quality-assurance control kits.
  - No OEM, brand, part number, or specific vendor is identified.
- **Notable product and delivery requirements**
  - Tests must be CLIA-waived for fingerstick whole blood or oral fluid and detect HCV-specific antibodies within 90 days after potential exposure or less. Kits may also detect HCV RNA for confirmatory testing, if available.
  - Products must have at least 12 months of shelf life upon delivery. Controls must be shipped with temperature protection that maintains their integrity and viability.
  - The supplier must process orders within 10 business days and deliver within 30 business days, provide shipment tracking, and notify DSHS of processing delays.
  - Required support includes training materials, product-performance information upon request, program coordination and reporting, and replacement of products that are expired, damaged, improperly temperature-controlled, or fail quality requirements.
- **Services and pricing**
  - Bidders must provide per-item pricing and shipping costs. The notice estimates the contract value at $1.4 million.
- **Period of performance**
  - The initial term runs from award through the end of May 2027. HHSC may add up to three one-year renewals, extending the term through May 2030, and may exercise an additional extension of up to one year.

### Description

The solicitation seeks FDA-approved, CLIA-waived rapid point-of-care tests for detecting hepatitis C virus antibodies, along with associated quality assurance test control kits. The goods are for the Department of State Health Services Pharmacy Inventory and Ordering System. The pricing materials list estimated annual quantities of 4,000 tests and 15 control kits, and request shipping costs. A completed subcontracting plan is required with the response.

[View original listing](https://www.txsmartbuy.gov/esbd/HHS0018069)
